.
MergerLinks Header Logo

New Deal


Announced

Naxicap Partners to acquire Ceres Pharma from Alychlo.

Financials

Edit Data
Transaction Value-
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Majority

Acquisition

Pending

Single Bidder

Private

Cross Border

Friendly

Belgium

pharmaceutical company

Pharmaceuticals

Private Equity

Synopsis

Edit

Naxicap Partners, a private equity firm, agreed to acquire Ceres Pharma, a Belgian based pharmaceutical company, from Alychlo, the family owned investment company founded by entrepreneur Marc Coucke. Financial terms were not disclosed. Naxicap Partners will support the company in further expanding its market position, helping it to realize its full potential. The focus will be on the company’s internationalization and further expansion in the BeNeLux, Central Europe, and potentially beyond, and on the development of new sales channels and the scaling of the marketing activities.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US